DIXIE COLGAN: Open Payments
NPI 1467859306 · HAMPSTEAD, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$914 in 43 payments from 10 companies in 2025. Trend: 2023 $1,219 · 2024 $860 · 2025 $914
Food & beverage: $914
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $198 |
| Novo Nordisk Inc | 7 | $174 |
| Orexo US, Inc. | 10 | $151 |
| AstraZeneca Pharmaceuticals LP | 5 | $123 |
| Exact Sciences Corporation | 4 | $91 |
| PFIZER INC. | 2 | $45 |
| Lilly USA, LLC | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Indivior Inc. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
Products named: Ozempic, Zubsolv, VRAYLAR, QULIPTA, Cologuard Collection Kit, BREZTRI, AIRSUPRA, NURTEC ODT.
Industry payments across MD — which companies pay providers there.
